Health Condition 1: B360- Pityriasis versicolor
Conditions
Interventions
Intervention1: Luliconazole 1% cream: Luliconazole 1% cream 0.5gm local application twice a day for 4 weeks
Control Intervention1: Sertaconazole 2% cream: Sertaconazole 2% cream 0.5gm local applicati
Sponsors
Chaitali Chindhalore
Eligibility
Inclusion criteria
Inclusion criteria: 1.1. Patients of either gender age between 18 years to 60 years 2. Suffering from pityriasis versicolor (mild) based on characteristic lesions, positive scratch sign, 3. Patients ready to give written informed consent
Exclusion criteria
Exclusion criteria: 1. Patients who had received systemic antifungal therapy within previous one month or topical antifungal treatment within a previous one week 2. Patients suffering from skin disorders other than PV. 3. Patients with a history of intolerance or hypersensitivity to the study drugs, 4. Patients suffering from severe concomitant illness or on systemic corticosteroids, anticancer or immunosuppressant drugs. 5. Pregnant and lactating females
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of patients achieving clinical cure 2.Percentage of patients achieving mycological cure 3.The change in global clinical response assessment 4.The change in Dermatology Life Quality Index (DLQI)Timepoint: at the end of 2 weeks and 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Treatment emergent adverse event-those reported by the subjects and those elicited by the clinician at follow-up visit Timepoint: at 2 weeks and 4 weeks | — |
Countries
India
Contacts
Public ContactDr Chaitali Ashish Chindhalore
AIIMS Nagpur
Outcome results
None listed